Case File
efta-02278091DOJ Data Set 11OtherEFTA02278091
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02278091
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Richard Kahn
From:
Lesley Groff
Subject ThuWWI
PM
Re:
I
I
Thx
Sent from my iPhone
On Jan 17, 2019, at 3:50 PM, Richard Kahn <richardkahn I 2@smail.com> wrote:
i will mention to jee when we speak next
thanks
Richard Kahn
HBRK Associates Inc.
575 Lexington Avenue 4th Floor
New York, NY 10022
On Jan 17, 2019, at 12:19 PM, Lesley Groff
wrote:
requested I forward you the below 'catch up' email.
<150636543')123blobjpg>
EFTA_R1_01093672
EFTA02278091
— Fo
From:
To: jeevacationCWnrr <am
Sent: Wednesday, January 16. 2019, 11:22:06 PM EST
Subject: Catching Up
Dear Jeffrey
I hope you've been well. I wanted to update you on what I've been up to for
the last two years. I was also hoping to talk with you to
see if I might use the foundation's Lexington office
conference room from time to time for my work and
what I could provide in exchange for that. I am cc'ing
Rich because I'm not sure if you still use this email?
Since working for your foundation, I continued to publish as a journalist
writing mostly about genetic vectors (Newsweek,
Techonomy etc). I then set up an LLC that provides
business development for labs that have reversed age-
driven or degenerative diseases. Most of the therapies are
genetic vectors, and have to show remarkable results at
the mouse level and beyond. Regenerative medicine is a
rapidly evolving field, and one that forces the medical
industry to shift their focus from addressing symptoms of
disease to fundamental evolutionary shortfalls.
So far, I placed a genetic vector at the National Institute of Medicine in
France (that reversed glaucoma in mice using the
ncuroglobin gene) under formal licence review with a
publicly traded pharma group here in the US. And I am
collaborating with a lab at the University of Pittsburgh
that has reversed cirrhosis/ end stage liver disease in rats
using the master transcription gene in hepatocytes. The
concept of the latter gene vector is really intriguing in
that a master transcription gene completely restored liver
function by rebalancing genetic expression and thus
proteostasis.
While I don't really need an office at this point, I do need access to a
conference room from time to time and it would be
hugely helpful if I could access the foundation's. If there
was some work that I could do for the foundation in
exchange, I would be delighted to do that.
EFTA_R1_0 1093673
EFTA02278092
It would be wonderful to catch up with you as well.
all the best,
<1506365439123b1ob.jpg>
<1506365439123blobjpg><1506365439123blobjpg>
EFTA_R1_01093674
EFTA02278093
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
2@smail.comPhone
2278091Phone
2278092Phone
2278093Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.